홈 › 다발성 골수종 › 펜실베이니아 › Philadelphia
PA Philadelphia의 다발성 골수종 임상 시험
다발성 골수종 관련 연구 16개가 Philadelphia 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
피험자 모집 중1상
- University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine, Philadelphia
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중3상
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
피험자 모집 중4상
- University of Pennsylvania, Philadelphia
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1/2상
- Penn Medicine, Philadelphia
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
피험자 모집 중2상
- Fox Chase Cancer Center, Philadelphia
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중2상
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
피험자 모집 중1/2상
- Research Site, Philadelphia
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
피험자 모집 중3상
- Thomas Jefferson University Hospital, Philadelphia
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
피험자 모집 중1상
- University of Pennsylvania, Philadelphia
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
피험자 모집 중1/2상
- ECOG-ACRIN Cancer Research Group, Philadelphia
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
피험자 모집 중1/2상
- Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
피험자 모집 중
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
피험자 모집 중3상
- Abramson Cancer Center University of Pennsylvania Medical Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
피험자 모집 중1/2상
- Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
피험자 모집 중2상
- Thomas Jefferson University Hospital, Philadelphia
Limited-duration Teclistamab
피험자 모집 중2상
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
다른 도시의 다발성 골수종 시험
- New York City, NY연구 60개
- Boston, MA연구 42개
- Atlanta, GA연구 41개
- Houston, TX연구 38개
- Durham, NC연구 37개
- Nashville, TN연구 32개
- Denver, CO연구 26개
- Rochester, MN연구 24개
- Columbus, OH연구 24개
- Baldwin Park, CA연구 23개
- St. Louis, MO연구 23개
- Chicago, IL연구 22개
Philadelphia의 다른 연구
- 암 (전체)연구 60개
- 유방암연구 56개
- 비소세포폐암연구 51개
- 전이성 암연구 46개
- 대장직장암연구 44개
- 난소암연구 44개
- 전립선암연구 44개
- 폐암연구 36개
- 급성 골수성 백혈병연구 34개
- 심부전연구 31개
- 자궁내막암연구 29개
- 두경부 편평세포암연구 26개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.